Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 8/20 | 0.34 |
| ▸ | KIF11 | P52732 | 6/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.31 |
| ▸ | SLC2A4 | P14672 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | OXTR | P30559 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4752894 | 1.00 | MGLL (0.34) | MGLLKIF11PDK2MEN1KMT2A | |
| SCHEMBL4749500 | 0.88 | — | — | |
| SCHEMBL4787104 | 0.86 | HRH4 (0.37) | MGLLMEN1KMT2A | |
| SCHEMBL4752082 | 0.86 | HRH4 (0.37) | MGLLMEN1KMT2A | |
| SCHEMBL4025189 | 0.86 | MGLL (0.38) | MGLLMEN1KMT2ASLC2A1SLC2A4 | |
| SCHEMBL4023658 | 0.86 | MGLL (0.38) | MGLLMEN1KMT2ASLC2A1SLC2A4 | |
| SCHEMBL4025192 | 0.86 | MGLL (0.38) | MGLLMEN1KMT2ASLC2A1SLC2A4 | |
| SCHEMBL4023656 | 0.86 | MGLL (0.38) | MGLLMEN1KMT2ASLC2A1SLC2A4 | |
| SCHEMBL4021758 | 0.84 | MGLL (0.36) | MGLLKIF11OPRD1OPRK1 | |
| SCHEMBL4021764 | 0.84 | MGLL (0.36) | MGLLKIF11OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008140810-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | CYTOKINETICS, INCORPORATED (US) | 2008-11-20 | — | — | WO | disclosed |